this 2020 paper is probably a better source Association Between Spending and Outcomes for Patients With Cancer https://www.ncbi.nlm.nih.gov/pmc/articles/PMC699

this 2020 paper is probably a better source Association Between Spending and Outcomes for Patients With Cancer https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994252/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994252/ ^ looks into more granular data, surveys sources that show +/0/- correlation between spending + outcomes, compares end-of-life vs non-end-of-life, cites a few studies about specific cancer types, wasteful spending. Does a better job of investigating international change in spending vs outcomes over time. the OP globocan paper is using a country average; averages don't tell you that much, esp in the US. cancer data is very granular these days (NY mandates per-case reporting, for example https://www.health.ny.gov/statistics/cancer/registry/about.htm https://www.health.ny.gov/statistics/cancer/registry/about.h...). would be interesting to have a live model somewhere of outcomes by cancer, stage, comorbidity + hospital